The awareness and use of cigarillos, heated tobacco and nicotine pouches is relatively low. This is apparent from research by RIVM among Dutch people aged 13 and older, commissioned by the Ministry of Health, Welfare and Sport.

RIVM and Nivel contribute to building a European RSV monitoring network. Through the network, European health institutions and laboratories will exchange data on the spread of RSV. This will help us to better monitor the virus. 

Compliance with coronavirus measures such as working from home, distancing and testing if you have symptoms decreased in the weeks leading up to the Cabinet’s recent press conference.

Today, fellow scientists and policymakers join the end symposium of the international project COHESIVE: One Health Structures in Europe.

The chance that a fully vaccinated person with the coronavirus SARS-CoV-2 will be admitted to hospital is 17 times lower than for a non-vaccinated person. The chance of ICU admission for a fully vaccinated person is 33 times lower.

The RIVM Magazine special edition on Climate change and Health showcases the scope of RIVM’s work on this topic.

RIVM is hosting an international workshop on new and emerging risks from chemicals on 20 and 21 February 2019.

Research by RIVM shows that the participants in the so-called tROM project, their supervisors and other people involved may have been exposed to chromium-6.

Recently, the EU-sponsored Vaccines and InfecTious diseases in the Ageing popuLation (VITAL) project was launched.

On November 19th 2018, RIVM organised an international expert meeting on a rare type of lymphoma that is associated with breast implants.